Lower GI 2017

The Royal Marsden Overall Survival by TRG (1-2 v 3 v 4-5) after Chemo-Radiotherapy in EXPERT-C trial (both arms)

mrTRG1-2 89.8%

65.9% 67.5%

mrTRG1-2, 39.8% mrTRG3 , 29% mrTRG4-5, 31%

Made with